Clinical trial
One Year Drug Treatment in First-Episode Schizophrenia
NCT00159081 · Heinrich-Heine University, Duesseldorf, Other · Completed
Key facts
| NCT number | NCT00159081 |
|---|---|
| Title | One Year Drug Treatment in First-Episode Schizophrenia |
| Official title | One Year Maintenance Treatment With Low Dose Haloperidol vs. Risperidone in First-Episode Schizophrenia |
| Lead sponsor | Heinrich-Heine University, Duesseldorf, Other |
| Collaborators | German Federal Ministry of Education and Research German Research Network On Schizophrenia Janssen-Cilag Ltd. Industry University of Bonn Humboldt-Universität zu Berlin University of München… |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Haloperidol, Risperidone (drug) |
| Enrollment | 159 |
| Start date | Nov 1, 2000 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 7, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: